Xylyx Bio and Alec Batis Partner to Launch Sweet Chemistry

Xylyx Bio, a regenerative medicine company, and Alec Batis, a research chemist, have forged a strategic collaboration to bring Sweet Chemistry, a new “evidence-based” regenerative skincare brand to market.

 

Sweet Chemistry represents what marketers call a “game-changing alliance” at the intersection of science and beauty by integrating Xylyx Bio's clinically proven Matrikynes regenerative peptides with Alec Batis' expertise in cosmetic science to create a transformative brand that transcends conventional skincare approaches. Matrikynes are clinically proven to improve the structure, function and appearance of damaged and aging skin. 

 

Science-based skincare is a large and growing market segment as consumers seek products backed by data, research and reliable information, with increasing demand for products that provide visible improvements coupled with transparency about ingredients and formulations that allow consumers to make informed choices.

 

“Xylyx Bio is driven by the pursuit of scientific innovation and a vision to redefine skincare through insights gained in regenerative medicine,” said Andrea Nye, CEO of Xylyx Bio. “By collaborating with Alec Batis, we are combining the reparative capabilities of Matrikynes with cosmetic excellence to introduce a new era in skincare.”

 

Sweet Chemistry is launching with two products, the Elasticity Reinforcing Cream and Reparative Oil-Serum Infusion. Each formulation boasts the highest standard of quality and efficacy. Products are dermatologist-tested, cruelty-free, and free from harmful chemicals, aligning with the partnership's shared commitment to sustainability and ethical practices.